NHS faces GLP-1 agonist shortage until 'at least end of 2024'

Supply of most GLP-1 agonists will continue to be constrained until at least the end of 2024 because of increased demand for 'licensed and off-label indications', prescribers have been warned.

by Chloe Harman and Nick Bostock

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now Register Now

Take a 30-day trial

  • Join MIMS now and pay nothing for the first 30 days
  • Join GPOnline now and pay nothing for the first 30 days

Sign Up Sign Up